SOCS1 (O15524) variants and mutations
SOCS1 (also known as O15524) is a human protein-coding gene encoding a suppressor of cytokine signaling 1 protein. It provides inducible negative feedback on cytokine signaling by inhibiting JAK kinases and promoting degradation of signaling components. Haploinsufficiency can cause early-onset autoimmunity and immune dysregulation, while somatic loss contributes to some lymphomas. This analysis covers 1,074 SOCS1 variants and mutations. Of these, 86% have computational variant effect predictions. Disease context includes autoinflammatory syndrome with immunodeficiency, diffuse large B-cell lymphoma, and psoriasis. Example SOCS1 variants include M1?, M1I, and V2*.
Variant analysis overview
- Gene: SOCS1
- Protein: O15524
- UniProt accession: O15524
- Organism: Homo sapiens
- Variants analyzed: 1074
- Variant scope: all variants
- Completed: 2026-08-20
Variant and mutation evidence
- Variant composition: 731 unspecified-consequence records; 3 stop lost; 1 stop retained variant; 154 synonymous variants; 153 missense variants; 16 frameshift variants; 7 stop-gained variants; 8 in-frame deletions; 1 in-frame insertions
- Prediction scores: 924 variants have prediction scores (86% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: autoinflammatory syndrome with immunodeficiency, diffuse large B-cell lymphoma, psoriasis, common variable immunodeficiency, lymphoma, psoriasis vulgaris, Hodgkins lymphoma, lymphoid neoplasm, non-functioning pituitary adenoma, neoplasm of mature B-cells, systemic lupus erythematosus, skin disorder.
Protein structure and variant hotspots
- Protein features: 2 domains.
- Structural context: 711 variants have structural context.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable SOCS1 variants
Examples include M1?, M1I, V2*, V2A, V2E, V2I, V2L, A3E. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- M1?, cosmic curated COSV59658, cosmic curated COSV59659, cosmic curated COSV10645
- M1I (p.Met1Ile), rs2511260094, ClinVar RCV004575003, Uncertain significance, not provided
- V2* (p.Val2Ter), cosmic curated COSV59660
- V2A (p.Val2Ala), cosmic curated COSV10524, 1000Genomes rs2141125567, REVEL 0.12, CADD 24.00
- V2E (p.Val2Glu), cosmic curated COSV10524, REVEL 0.20, CADD 26.80
- V2I (p.Val2Ile), cosmic curated COSV59658, REVEL 0.12, CADD 23.70
- V2L (p.Val2Leu), cosmic curated COSV59661, REVEL 0.11, CADD 23.80
- A3E (p.Ala3Glu), cosmic curated COSV59659, REVEL 0.05, CADD 24.30
- A3G (p.Ala3Gly), cosmic curated COSV10524
- A3P (p.Ala3Pro), cosmic curated COSV59661, 1000Genomes rs2069587706
- A3R (p.Ala3Arg), cosmic curated COSV59659, MetaLR 0.04, MetaSVM -1.08
- A3S (p.Ala3Ser), cosmic curated COSV10524, REVEL 0.08, CADD 24.00
- A3T (p.Ala3Thr), cosmic curated COSV59658, REVEL 0.08, CADD 26.40, Tier I - Strong, Malignant lymphoma, large B-cell, diffuse
- A3V (p.Ala3Val), cosmic curated COSV59659, REVEL 0.09, CADD 24.80
- H4D (p.His4Asp), cosmic curated COSV10524
- H4L (p.His4Leu), Ensembl rs1450518689, MetaLR 0.02, MetaSVM -1.06
- H4Q (p.His4Gln), cosmic curated COSV10964, REVEL 0.04, CADD 23.00
- H4R (p.His4Arg), Ensembl rs1450518689, REVEL 0.03, CADD 23.10
- H4Y (p.His4Tyr), gnomAD rs1250254695, REVEL 0.04, CADD 23.60
- N5D (p.Asn5Asp), cosmic curated COSV10524, REVEL 0.04, CADD 22.50
- N5I (p.Asn5Ile), cosmic curated COSV59659, MetaLR 0.03, MetaSVM -1.09
- N5K (p.Asn5Lys), cosmic curated COSV10524, REVEL 0.03, CADD 22.30
- N5S (p.Asn5Ser), cosmic curated COSV59659, REVEL 0.11, CADD 18.60
- Q6* (p.Gln6Ter), cosmic curated COSV59659, CADD 39.00
- Q6E (p.Gln6Glu), rs587778692, ClinGen CA162192, cosmic curated COSV10524, ClinVar RCV000122087, REVEL 0.04, CADD 18.60, not provided, not specified
- Q6H (p.Gln6His), cosmic curated COSV59658, cosmic curated COSV10524, REVEL 0.05, CADD 22.90
- Q6P (p.Gln6Pro), 1000Genomes rs2141125550, REVEL 0.10, CADD 23.00
- V7A (p.Val7Ala), cosmic curated COSV10524, REVEL 0.11, CADD 26.50
- V7L (p.Val7Leu), cosmic curated COSV10524, REVEL 0.10, CADD 25.40
- A8E (p.Ala8Glu), cosmic curated COSV10645, REVEL 0.03, CADD 22.20
- A8S (p.Ala8Ser), cosmic curated COSV10524, Ensembl rs2141125543, REVEL 0.02, CADD 20.30
- A8T (p.Ala8Thr), Ensembl rs2141125543, REVEL 0.04, CADD 21.40
- A8V (p.Ala8Val), Ensembl rs2141125539, REVEL 0.08, CADD 23.20
- A9G (p.Ala9Gly), cosmic curated COSV10524, REVEL 0.11, CADD 23.70
- A9P (p.Ala9Pro), TOPMed rs972082256, REVEL 0.09, CADD 23.80
- A9T (p.Ala9Thr), TOPMed rs972082256, REVEL 0.06, CADD 23.90
- A9V (p.Ala9Val), cosmic curated COSV59659, Ensembl rs2141125525, REVEL 0.09, CADD 24.50
- D10A (p.Asp10Ala), Ensembl rs2141125513
- D10H (p.Asp10His), Ensembl rs2069587396, REVEL 0.14, CADD 26.30
- D10N (p.Asp10Asn), Ensembl rs2069587396, REVEL 0.07, CADD 23.90
- D10V (p.Asp10Val), Ensembl rs2141125513, MetaLR 0.08, MetaSVM -1.11
- N11I (p.Asn11Ile), ExAC rs772431210, TOPMed rs772431210, gnomAD rs772431210, REVEL 0.08, CADD 27.80
- N11K (p.Asn11Lys), cosmic curated COSV10883, REVEL 0.03, CADD 26.30
- N11S (p.Asn11Ser), ExAC rs772431210, TOPMed rs772431210, gnomAD rs772431210, REVEL 0.05, CADD 23.50
- N11T (p.Asn11Thr), cosmic curated COSV10524, MetaLR 0.05, MetaSVM -1.11
- A12E (p.Ala12Glu), cosmic curated COSV59660, REVEL 0.07, CADD 24.40
- A12P (p.Ala12Pro), cosmic curated COSV10524
- A12R (p.Ala12Arg), NCI-TCGA TCGA novel, MetaLR 0.07, MetaSVM -1.12, Variant assessed as somatic; high impact.
- A12S (p.Ala12Ser), cosmic curated COSV10524, REVEL 0.10, CADD 23.70
- A12T (p.Ala12Thr), TOPMed rs2069587366, REVEL 0.05, CADD 22.90
- A12V (p.Ala12Val), Ensembl rs2141125500, REVEL 0.05, CADD 24.70
- V13F (p.Val13Phe), ExAC rs200748141, TOPMed rs200748141, gnomAD rs200748141, REVEL 0.04, CADD 23.00
- V13I (p.Val13Ile), cosmic curated COSV10606, REVEL 0.09, CADD 15.60
- V13L (p.Val13Leu), cosmic curated COSV10524, ExAC rs200748141, TOPMed rs200748141, gnomAD rs200748141, REVEL 0.07, CADD 19.60
- S14A (p.Ser14Ala), rs778594186, ClinGen CA7902325, ClinVar RCV004109494, ExAC rs778594186, REVEL 0.04, CADD 21.00, Uncertain significance, not specified
- S14C (p.Ser14Cys), cosmic curated COSV10524, REVEL 0.04, CADD 24.20
- S14F (p.Ser14Phe), cosmic curated COSV10524, Ensembl rs1015351316, REVEL 0.03, CADD 24.30
- S14P (p.Ser14Pro), ExAC rs778594186, gnomAD rs778594186, REVEL 0.05, CADD 23.10, Uncertain significance
- T15A (p.Thr15Ala), cosmic curated COSV10739, REVEL 0.10, CADD 14.70
- T15I (p.Thr15Ile), cosmic curated COSV10739, 1000Genomes rs753381473, ExAC rs753381473, TOPMed rs753381473, REVEL 0.09, CADD 22.60
- A16G (p.Ala16Gly), cosmic curated COSV10524, MetaLR 0.03, MetaSVM -1.03
- A16P (p.Ala16Pro), rs537872317, ClinGen CA7902322, cosmic curated COSV59660, ClinVar RCV003399708, REVEL 0.03, CADD 20.50, Uncertain significance, SOCS1-related disorder
- A16S (p.Ala16Ser), cosmic curated COSV59661, 1000Genomes rs537872317, ExAC rs537872317, TOPMed rs537872317, REVEL 0.03, CADD 18.20, Uncertain significance
- A16T (p.Ala16Thr), cosmic curated COSV59658, 1000Genomes rs537872317, ExAC rs537872317, TOPMed rs537872317, REVEL 0.05, CADD 19.30, Uncertain significance
- A16V (p.Ala16Val), cosmic curated COSV10524, Ensembl rs2141125485, REVEL 0.03, CADD 23.00
- A17E (p.Ala17Glu), cosmic curated COSV59661, REVEL 0.10, CADD 22.60
- A17G (p.Ala17Gly), cosmic curated COSV10645
- A17P (p.Ala17Pro), NCI-TCGA Cosmic COSV5965, NCI-TCGA Cosmic COSV5966, cosmic curated COSV59661, Variant assessed as somatic; moderate impact.
- A17S (p.Ala17Ser), cosmic curated COSV59659, REVEL 0.04, CADD 17.00
- A17T (p.Ala17Thr), cosmic curated COSV59659, TOPMed rs1408866546, gnomAD rs1408866546, REVEL 0.05, CADD 18.60
- A17V (p.Ala17Val), cosmic curated COSV10524, REVEL 0.07, CADD 23.10
- E18* (p.Glu18Ter), cosmic curated COSV10440, CADD 38.00
- E18G (p.Glu18Gly), ExAC rs755719591, TOPMed rs755719591, gnomAD rs755719591, REVEL 0.05, CADD 23.50
- E18K (p.Glu18Lys), cosmic curated COSV59659, TOPMed rs1163730492, gnomAD rs1163730492, REVEL 0.08, CADD 22.90
- E18Q (p.Glu18Gln), cosmic curated COSV59659, TOPMed rs1163730492, gnomAD rs1163730492, REVEL 0.09, CADD 22.30
- E18V (p.Glu18Val), ExAC rs755719591, TOPMed rs755719591, gnomAD rs755719591, REVEL 0.05, CADD 24.50
- P19A (p.Pro19Ala), cosmic curated COSV10524
- P19L (p.Pro19Leu), rs2511259988, ClinGen CA394740835, ClinVar RCV004094254, REVEL 0.05, CADD 22.90, Uncertain significance, not specified
- P19R (p.Pro19Arg), rs2511259988, ClinGen CA394740836, ClinVar RCV004105644, Uncertain significance, not specified
- P19S (p.Pro19Ser), cosmic curated COSV10524, 1000Genomes rs1028027657, TOPMed rs1028027657, gnomAD rs1028027657, REVEL 0.04, CADD 18.50
- P19T (p.Pro19Thr), 1000Genomes rs1028027657, TOPMed rs1028027657, gnomAD rs1028027657, REVEL 0.05, CADD 17.90
- R20* (p.Arg20Ter), 1000Genomes rs182726276, ExAC rs182726276, CADD 39.00
- R20L (p.Arg20Leu), cosmic curated COSV59660, ExAC rs767406182, TOPMed rs767406182, gnomAD rs767406182, REVEL 0.07, CADD 27.30
- R20P (p.Arg20Pro), ExAC rs767406182, TOPMed rs767406182, gnomAD rs767406182
- R21W (p.Arg21Trp), rs759348389, ClinGen CA7902318, ClinVar RCV004464761, ExAC rs759348389, REVEL 0.06, CADD 25.60, Uncertain significance, not specified
- R22Q (p.Arg22Gln), ExAC rs751378699, TOPMed rs751378699, gnomAD rs751378699, REVEL 0.09, CADD 22.90, Uncertain significance, not specified
- R22W (p.Arg22Trp), rs2069586831, ClinGen CA394740825, ClinVar RCV001254900, ClinVar RCV001526872, REVEL 0.07, CADD 25.40, Pathogenic/Likely pathogenic, AUTOINFLAMMATORY SYNDROME, FAMILIAL, WITHOUT IMMUNODEFICIENCY; Systemic lupus er
- P23A (p.Pro23Ala), gnomAD rs1486450287
- P23R (p.Pro23Arg), TOPMed rs2069586736, REVEL 0.05, CADD 23.00
- P23S (p.Pro23Ser), gnomAD rs1486450287, REVEL 0.02, CADD 21.60
- E24* (p.Glu24Ter), cosmic curated COSV10524, CADD 40.00
- E24A (p.Glu24Ala), cosmic curated COSV10524
- E24K (p.Glu24Lys), rs2511259967, ClinGen CA394740816, ClinVar RCV004555969, cosmic curated COSV59660, REVEL 0.09, CADD 23.30, Uncertain significance, Autoinflammatory syndrome with immunodeficiency
- E24Q (p.Glu24Gln), cosmic curated COSV10524, MetaLR 0.03, MetaSVM -1.04
- P25A (p.Pro25Ala), cosmic curated COSV10524, ExAC rs765434194, TOPMed rs765434194, gnomAD rs765434194, Uncertain significance
- P25R (p.Pro25Arg), cosmic curated COSV59659, MetaLR 0.04, MetaSVM -1.10
- P25S (p.Pro25Ser), rs765434194, NCI-TCGA Cosmic COSV5965, cosmic curated COSV59658, ExAC rs765434194, REVEL 0.07, CADD 18.50, Uncertain significance, not specified
- S26F (p.Ser26Phe), TOPMed rs1419275878, gnomAD rs1419275878, REVEL 0.03, CADD 24.70
- S26P (p.Ser26Pro), Ensembl rs2069586680, REVEL 0.03, CADD 22.90
- S26Y (p.Ser26Tyr), TOPMed rs1419275878, gnomAD rs1419275878, REVEL 0.02, CADD 24.40
- S27F (p.Ser27Phe), rs1249424944, ClinGen CA394740792, cosmic curated COSV59659, ClinVar RCV003426587, REVEL 0.03, CADD 25.20, Uncertain significance, not provided
- S28F (p.Ser28Phe), cosmic curated COSV59660, TOPMed rs1359050527, gnomAD rs1359050527, REVEL 0.05, CADD 23.10
- S28P (p.Ser28Pro), 1000Genomes rs2141125399, REVEL 0.07, CADD 21.60
- S29F (p.Ser29Phe), cosmic curated COSV10524, Ensembl rs1597691601, REVEL 0.06, CADD 28.90
- S29P (p.Ser29Pro), cosmic curated COSV10524, REVEL 0.07, CADD 23.30
- S30F (p.Ser30Phe), Ensembl rs2141125386, REVEL 0.15, CADD 24.60
- S31F (p.Ser31Phe), cosmic curated COSV10524, REVEL 0.06, CADD 23.50
- S32* (p.Ser32Ter), rs2141125364, ClinGen CA394740763, ClinVar RCV001531222, Ensembl rs2141125364, CADD 39.00, Likely pathogenic
- S32L (p.Ser32Leu), Ensembl rs2141125364, REVEL 0.07, CADD 22.40, Likely pathogenic
- P33S (p.Pro33Ser), cosmic curated COSV10524, Ensembl rs2141125355, REVEL 0.01, CADD 2.83
- A34E (p.Ala34Glu), cosmic curated COSV10582, REVEL 0.04, CADD 8.36
- A34P (p.Ala34Pro), Ensembl rs1233626909, REVEL 0.04, CADD 13.20
- A34S (p.Ala34Ser), cosmic curated COSV10739, REVEL 0.01, CADD 9.26
- A34T (p.Ala34Thr), rs1233626909, ClinGen CA394740755, ClinVar RCV003222860, REVEL 0.02, CADD 11.50, Uncertain significance, not provided
- A34V (p.Ala34Val), TOPMed rs1019392987, REVEL 0.01, CADD 7.90, Uncertain significance, not specified
- p.Ala34 Ala47del, rs887945064, gnomAD 16-11255337-GGGCC, CADD 19.80
- A35D (p.Ala35Asp), cosmic curated COSV10524, REVEL 0.03, CADD 10.70
- A35P (p.Ala35Pro), rs998577469, ClinGen CA278232800, ClinVar RCV004213643, TOPMed rs998577469, REVEL 0.08, CADD 13.90, Uncertain significance, not specified
- A35T (p.Ala35Thr), NCI-TCGA Cosmic COSV1001, cosmic curated COSV10013, TOPMed rs998577469, gnomAD rs998577469, REVEL 0.03, CADD 12.40, Uncertain significance
- A35V (p.Ala35Val), Ensembl rs2141125339, REVEL 0.01, CADD 12.40
- p.Ala35 Ala44del, rs750807426, gnomAD 16-11255345-ACCGC, CADD 20.10
- P36A (p.Pro36Ala), rs867464575, ClinGen CA278232799, ClinVar RCV004150412, TOPMed rs867464575, REVEL 0.07, CADD 16.70, Uncertain significance, not specified
- P36L (p.Pro36Leu), cosmic curated COSV59660, REVEL 0.03, CADD 17.20
- P36S (p.Pro36Ser), NCI-TCGA TCGA novel, TOPMed rs867464575, gnomAD rs867464575, REVEL 0.07, CADD 18.90, Uncertain significance
- A37P (p.Ala37Pro), TOPMed rs2069586201, REVEL 0.04, CADD 17.10
- A37T (p.Ala37Thr), TOPMed rs2069586201, REVEL 0.08, CADD 15.80
- p.Ala37 Pro50del, rs1567455544, gnomAD 16-11255327-CCGGG, CADD 22.00
- R38C (p.Arg38Cys), cosmic curated COSV59660, REVEL 0.05, CADD 25.20
- R38L (p.Arg38Leu), gnomAD rs1248355267, REVEL 0.08, CADD 22.50
- R38P (p.Arg38Pro), gnomAD rs1248355267, REVEL 0.07, CADD 22.50
- p.Arg38 Ala49del, rs1239337863, gnomAD 16-11255335-CGGGG, CADD 19.90
- P39Q (p.Pro39Gln), cosmic curated COSV59661, REVEL 0.03, CADD 16.80
- P39R (p.Pro39Arg), ExAC rs776843433, TOPMed rs776843433, gnomAD rs776843433, REVEL 0.02, CADD 15.90
- R40P (p.Arg40Pro), Ensembl rs2141125321, MetaLR 0.07, MetaSVM -1.10
- R40W (p.Arg40Trp), TOPMed rs1287870158, gnomAD rs1287870158, REVEL 0.08, CADD 26.60
- P41L (p.Pro41Leu), cosmic curated COSV10524, cosmic curated COSV59661, REVEL 0.04, CADD 17.10
- P41S (p.Pro41Ser), gnomAD rs1240652971, REVEL 0.01, CADD 21.90, Uncertain significance, not provided
- C42* (p.Cys42Ter), cosmic curated COSV59658, CADD 37.00
- C42F (p.Cys42Phe), gnomAD rs1306590732, REVEL 0.05, CADD 19.30
- C42G (p.Cys42Gly), Ensembl rs2141125305, MetaLR 0.03, MetaSVM -1.04
- C42S (p.Cys42Ser), gnomAD rs1306590732, REVEL 0.05, CADD 15.50
- C42Y (p.Cys42Tyr), cosmic curated COSV59662, gnomAD rs1306590732, REVEL 0.07, CADD 18.80
- P43L (p.Pro43Leu), cosmic curated COSV10964, gnomAD rs1369823773, REVEL 0.01, CADD 8.67
- P43S (p.Pro43Ser), cosmic curated COSV59659, REVEL 0.01, CADD 17.30
- A44P (p.Ala44Pro), gnomAD rs2069585860, REVEL 0.04, CADD 13.70
- A44T (p.Ala44Thr), gnomAD rs2069585860, REVEL 0.05, CADD 12.90
- A44V (p.Ala44Val), Ensembl rs2141125290, REVEL 0.03, CADD 14.90
- A44G (p.Ala44Gly), gnomAD 16-11255334-CCGGG, CADD 29.20
- V45A (p.Val45Ala), Ensembl rs1227633279, REVEL 0.02, CADD 3.15
- V45G (p.Val45Gly), Ensembl rs1227633279
- V45I (p.Val45Ile), cosmic curated COSV59659, gnomAD rs2069585803, REVEL 0.04, CADD 14.10
- V45L (p.Val45Leu), cosmic curated COSV59661, gnomAD rs2069585803
- V45V (p.Val45Val), gnomAD 16-11255344-G-A, CADD 3.85
- V45D (p.Val45Asp), gnomAD 16-11255345-A-T, REVEL 0.02, MetaLR 0.03
- P46L (p.Pro46Leu), TOPMed rs1404861826, gnomAD rs1404861826, REVEL 0.06, CADD 21.20
- P46S (p.Pro46Ser), cosmic curated COSV10942, NCI-TCGA TCGA novel, Ensembl rs2141125272, REVEL 0.06, CADD 16.50, Variant assessed as somatic; moderate impact.
- P46R (p.Pro46Arg), gnomAD 16-11255341-CG-C, CADD 25.60
- P46P (p.Pro46Pro), gnomAD 16-11255341-C-T, CADD 7.19
- P46Q (p.Pro46Gln), gnomAD 16-11255342-G-T, REVEL 0.04, MetaLR 0.03
- P46T (p.Pro46Thr), gnomAD 16-11255343-G-T, REVEL 0.05, MetaLR 0.04
- A47D (p.Ala47Asp), cosmic curated COSV10524, REVEL 0.03, CADD 13.10
- A47G (p.Ala47Gly), cosmic curated COSV10524, REVEL 0.02, CADD 11.80
- A47P (p.Ala47Pro), ExAC rs768681189, TOPMed rs768681189, gnomAD rs768681189
- A47S (p.Ala47Ser), ExAC rs768681189, TOPMed rs768681189, gnomAD rs768681189, REVEL 0.01, CADD 10.50
- A47T (p.Ala47Thr), rs768681189, ClinGen CA394740679, ClinVar RCV002510339, REVEL 0.01, CADD 13.30, Uncertain significance, not specified
- A47V (p.Ala47Val), rs985283832, ClinGen CA278232797, ClinVar RCV004464756, TOPMed rs985283832, REVEL 0.03, CADD 11.70, Uncertain significance, not specified
- A47A (p.Ala47Ala), rs2069585554, gnomAD 16-11255338-G-A, CADD 7.58
- P48A (p.Pro48Ala), cosmic curated COSV10524, REVEL 0.03, CADD 14.20
- P48L (p.Pro48Leu), TOPMed rs1185653650, gnomAD rs1185653650, REVEL 0.05, CADD 20.50
- P48R (p.Pro48Arg), TOPMed rs1185653650, gnomAD rs1185653650, REVEL 0.04, CADD 19.50
- P48S (p.Pro48Ser), TOPMed rs1300398340, gnomAD rs1300398340, REVEL 0.03, CADD 15.70
- P48P (p.Pro48Pro), gnomAD 16-11255335-C-A, CADD 11.10
- P48Q (p.Pro48Gln), gnomAD 16-11255336-G-T, REVEL 0.04, MetaLR 0.03
- P48T (p.Pro48Thr), gnomAD 16-11255337-G-T, REVEL 0.02, MetaLR 0.03
- A49G (p.Ala49Gly), TOPMed rs1156507872, gnomAD rs1156507872, REVEL 0.06, CADD 18.70
- A49P (p.Ala49Pro), 1000Genomes rs760692169, ExAC rs760692169, TOPMed rs760692169, gnomAD rs760692169, REVEL 0.09, CADD 22.00, Uncertain significance
- A49S (p.Ala49Ser), rs760692169, ClinGen CA7902310, ClinVar RCV004464757, 1000Genomes rs760692169, REVEL 0.05, CADD 13.60, Uncertain significance, not specified
- A49T (p.Ala49Thr), 1000Genomes rs760692169, ExAC rs760692169, TOPMed rs760692169, gnomAD rs760692169, REVEL 0.03, CADD 16.60, Uncertain significance
- A49V (p.Ala49Val), rs1156507872, NCI-TCGA Cosmic COSV1001, cosmic curated COSV10013, TOPMed rs1156507872, REVEL 0.07, CADD 19.60, Variant assessed as somatic; moderate impact.
- p.Ala49 Pro50del, rs587778691, gnomAD 16-11255329-GGGGG, CADD 22.20
Public SOCS1 analysis runs
- SOCS1 analysis run — SOCS1 (1,074 variants) — completed 2026-08-20